USpharma Ltd. Attracts Significant Investment for Growth Initiatives - Third News
Summary
USpharma Ltd. secured a substantial equity investment from 1315 Capital to accelerate its growth plans. The company develops pharmaceutical and dietary supplement products using patented formulation technologies and a GMP manufacturing facility in the United States. Management said the capital will help expand the pipeline, improve operations, and broaden access to its health solutions. The investment strengthens USpharma’s ability to scale production and compete more aggressively in healthcare markets.
Funding
Amount
None
Total raised
Date
June 30, 2025
Announcement date
Investors
1315 Capital
Lead investors
Company
uspharmaltd.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected